FdaApplication
NDA 214012
Identifiers
- fda_app_no: NDA214012
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2021-12-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEQVIO | INCLISIRAN SODIUM | EQ 284MG BASE/1.5ML (EQ 189MG BASE/ML) | SOLUTION;SUBCUTANEOUS |
1 product